Literature DB >> 18200531

Proteins and peptides: strategies for delivery to and across the skin.

Heather A E Benson1, Sarika Namjoshi.   

Abstract

Despite the increased availability of therapeutic proteins and peptides, delivery remains almost entirely via hypodermic needle. Transdermal delivery offers an attractive noninvasive route of administration but is limited by the skin's barrier to penetration. Extensive research has been directed at developing effective methods to enhance delivery of peptides and proteins to and across the skin. Strategies include formulation optimisation, conjugation to increase peptide lipophilicity and incorporation of chemical or biological modifiers to transiently reduce stratum corneum barrier function. A number of physical technologies, including iontophoresis, electroporation and sonophoresis, have been developed that apply different forms of energy to disrupt the barrier. In addition, minimally invasive techniques, such as microneedles and jet propulsion, bypass the stratum corneum barrier to permit direct access to the viable epidermis. This article reviews the current state of the art in the delivery of proteins and peptides to and across the skin.

Mesh:

Substances:

Year:  2008        PMID: 18200531     DOI: 10.1002/jps.21277

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  20 in total

1.  Transdermal monosialoganglioside with laser in the treatment of spinal cord lesion in rats.

Authors:  Fabiano Inácio de Souza; Alexandre Fogaça Cristante; Raphael Martus Marcon; Ricardo Ferreira; Gustavo Bispo Dos Santos; Tarcísio Eloy Pessoa de Barros Filho
Journal:  Acta Ortop Bras       Date:  2013-03       Impact factor: 0.513

2.  Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.

Authors:  Katarzyna Migalska; Desmond I J Morrow; Martin J Garland; Raj Thakur; A David Woolfson; Ryan F Donnelly
Journal:  Pharm Res       Date:  2011-03-25       Impact factor: 4.200

3.  Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: Comparative in vitro studies with full-thickness and split-thickness pig and human skin.

Authors:  Jennifer E Seto; Baris E Polat; Renata F V Lopez; Daniel Blankschtein; Robert Langer
Journal:  J Control Release       Date:  2010-03-25       Impact factor: 9.776

4.  Fractional thermolysis by bipolar radiofrequency facilitates cutaneous delivery of peptide and siRNA with minor loss of barrier function.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Chi-Kuang Sun; Ibrahim A Aljuffali; Shih-Yun Suen; Yin-Ku Lin; Jhi-Joung Wang; Jia-You Fang
Journal:  Pharm Res       Date:  2014-11-13       Impact factor: 4.200

5.  Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mechanistic insights.

Authors:  Sarika Namjoshi; Istvan Toth; Joanne T Blanchfield; Nicholas Trotter; Ricardo L Mancera; Heather A E Benson
Journal:  Pharm Res       Date:  2014-05-21       Impact factor: 4.200

6.  Iontophoretic skin permeation of peptides: an investigation into the influence of molecular properties, iontophoretic conditions and formulation parameters.

Authors:  Gayathri Krishnan; Michael S Roberts; Jeffrey Grice; Yuri G Anissimov; Hamid R Moghimi; Heather A E Benson
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

7.  Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering.

Authors:  Volker Spindler; Vera Rötzer; Carina Dehner; Bettina Kempf; Martin Gliem; Mariya Radeva; Eva Hartlieb; Gregory S Harms; Enno Schmidt; Jens Waschke
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

Review 8.  Transdermal drug delivery: feasibility for treatment of superficial bone stress fractures.

Authors:  Ali Aghazadeh-Habashi; Yang Yang; Kathy Tang; Raimar Lőbenberg; Michael R Doschak
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

Review 9.  Delivery of therapeutic proteins.

Authors:  Dipak S Pisal; Matthew P Kosloski; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

10.  Enhancement of Wound Healing Efficacy by Increasing the Stability and Skin-Penetrating Property of bFGF Using 30Kc19α-Based Fusion Protein.

Authors:  Haein Lee; Young-Hyeon An; Tae Keun Kim; Jina Ryu; G Kate Park; Mihn Jeong Park; Junghyeon Ko; Hyunbum Kim; Hak Soo Choi; Nathaniel S Hwang; Tai Hyun Park
Journal:  Adv Biol (Weinh)       Date:  2021-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.